Total Payments
$1,071
2024 Payments
$623.85
Companies
21
Transactions
45
Medicare Patients
1,360
Medicare Billing
$166,144
Payment Breakdown by Category
Food & Beverage$1,071 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,071 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ASD Specialty Healthcare, LLC | $192.94 | 3 | $0 (2018) |
| GENZYME CORPORATION | $140.36 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $95.22 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $88.78 | 4 | $0 (2024) |
| Daiichi Sankyo Inc. | $73.59 | 4 | $0 (2024) |
| Deciphera Pharmaceuticals Inc. | $60.92 | 3 | $0 (2024) |
| ABBVIE INC. | $52.28 | 2 | $0 (2024) |
| PFIZER INC. | $44.53 | 3 | $0 (2024) |
| Pharmacosmos Therapeutics Inc. | $38.80 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $33.37 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $623.85 | 30 | GENZYME CORPORATION ($140.36) |
| 2023 | $253.96 | 12 | Merck Sharp & Dohme LLC ($53.90) |
| 2018 | $192.94 | 3 | ASD Specialty Healthcare, LLC ($192.94) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Geron Corporation | RYTELO (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/06/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $38.80 | General |
| Category: HEMATOLOGY | ||||||
| 12/05/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug), TGCT | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Genentech USA, Inc. | Itovebi (Biological), Phesgo, Tecentriq | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: BioOncology | ||||||
| 11/21/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Hematology | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.42 | General |
| 11/15/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $31.46 | General |
| 11/13/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Hematology | ||||||
| 10/02/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Hematology | ||||||
| 09/30/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Oncology | ||||||
| 09/26/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Hematology | ||||||
| 08/28/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Hematology | ||||||
| 08/27/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Hematology | ||||||
| 07/24/2024 | GENZYME CORPORATION | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: Hematology | ||||||
| 07/16/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $33.77 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: ONCOLOGY | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Oncology | ||||||
| 06/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 138 | 174 | $54,102 | $13,400 |
| 2022 | 9 | 468 | 665 | $220,985 | $73,344 |
| 2021 | 6 | 364 | 462 | $175,714 | $43,611 |
| 2020 | 6 | 390 | 624 | $210,419 | $35,789 |
Total Patients
1,360
Total Services
1,925
Medicare Billing
$166,144
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 59 | $18,794 | $4,937 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 37 | $17,352 | $4,416 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $9,368 | $2,010 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 39 | $8,082 | $1,853 | 22.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 22 | $506.00 | $184.80 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 237 | $56,406 | $24,063 | 42.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 71 | 136 | $53,856 | $19,188 | 35.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 82 | 82 | $32,144 | $10,727 | 33.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 48 | 48 | $25,392 | $7,695 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 68 | $11,424 | $5,175 | 45.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 40 | $15,080 | $2,398 | 15.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $14,020 | $2,293 | 16.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 13 | $6,825 | $1,118 | 16.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 18 | 21 | $5,838 | $686.37 | 11.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 164 | 224 | $75,955 | $16,088 | 21.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 63 | 91 | $39,731 | $11,165 | 28.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 43 | 43 | $23,582 | $7,631 | 32.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 53 | 53 | $23,534 | $6,127 | 26.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 17 | 26 | $7,214 | $1,520 | 21.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 25 | $5,698 | $1,080 | 19.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 160 | 309 | $110,107 | $16,688 | 15.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 98 | 143 | $34,896 | $5,681 | 16.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 57 | 90 | $20,758 | $5,294 | 25.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 37 | 37 | $19,941 | $3,662 | 18.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 23 | 30 | $14,464 | $2,373 | 16.4% |
About Dr. Robert Klafter, M.D
Dr. Robert Klafter, M.D is a Hematology & Oncology healthcare provider based in Stockbridge, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558360446.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Klafter, M.D has received a total of $1,071 in payments from pharmaceutical and medical device companies, with $623.85 received in 2024. These payments were reported across 45 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,071).
As a Medicare-enrolled provider, Klafter has provided services to 1,360 Medicare beneficiaries, totaling 1,925 services with total Medicare billing of $166,144. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Stockbridge, GA
- Active Since 07/21/2005
- Last Updated 03/02/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1558360446
Products in Payments
- CABLIVI (Biological) $140.36
- KEYTRUDA (Biological) $95.22
- Enhertu (Drug) $73.59
- QINLOCK (Drug) $60.92
- INLYTA (Drug) $44.53
- MONOFERRIC (Drug) $38.80
- IMBRUVICA (Drug) $33.77
- DARZALEX (Biological) $33.37
- KRAZATI (Drug) $32.72
- Xermelo (Drug) $27.26
- Vitrakvi (Drug) $26.97
- Tibsovo (Drug) $24.95
- LORBRENA (Drug) $20.99
- KISQALI (Drug) $18.52
- CREON (Drug) $18.51
- Itovebi (Biological) $18.16
- OJJAARA (Drug) $17.44
- ENHERTU (Biological) $17.15
- RYTELO (Drug) $14.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Stockbridge
Dr. Jorge Spinolo, Md, MD
Hematology & Oncology — Payments: $22,986
Hematology & Oncology $22,986
Gurinderjit Kaur Sidhu, Md, MD
Hematology & Oncology — Payments: $5,967
Hematology & Oncology $5,967
Dr. Anthony Onyegbula, D.o, D.O
Hematology & Oncology — Payments: $4,685
Hematology & Oncology $4,685
Lijo Simpson, Mbbs, MBBS
Hematology & Oncology — Payments: $4,517
Hematology & Oncology $4,517
Dr. Ruth Sarmiento, M.d, M.D
Hematology & Oncology — Payments: $3,789
Hematology & Oncology $3,789
Dr. Ha Tran, M.d, M.D
Hematology & Oncology — Payments: $2,994
Hematology & Oncology $2,994